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Alzheimer’s disease (AD) is the most common form of dementia aﬀecting millions of people worldwide and will continue to
aﬀect millions more with population aging on the rise. AD causality is multifactorial. Known causal factors include genetic
predisposition, age, and sex. Environmental toxins such as air pollution (AP) have also been implicated in AD causation. Exposure
to AP can lead to chronic oxidative stress (OS), which is involved in the pathogenesis of AD. Whereas AP plays a role in AD
pathology, the epidemiological evidence for this association is limited. Given the signiﬁcant prevalence of AP exposure combined
with increased population aging, epidemiological evidence for this link is important to consider. In this paper, we examine the
existing evidence supporting the relationship between AP, OS, and AD and provide recommendations for future research on the
population level, which will provide evidence in support of public health interventions.
1.Introduction
Air pollution is a well-known environmental hazard and its
association with respiratory and cardiovascular pathology
has been consistently conﬁrmed by several epidemiological
studies. In recent years, the idea that air pollution might
be also associated with Alzheimer’s disease (AD) and other
neurodegenerative disorders has been the focus of many
toxicological studies. However, the epidemiological evidence
supporting this association is limited.
Alzheimer’s disease—a progressive and irreversible neu-
rodegenerative disorder—is the most common form of
dementia among older adults aﬀecting more than 4 million
people in the USA and almost 30 million worldwide [1–3].
The most proven risk factor for AD is advanced age. Other
common risk factors include a positive family history of AD
[1], the presence of APOE-4 alleles [4, 5], being a member
of the female sex [6], cardiovascular disease [7], head injury
[8], Down syndrome [1, 9], and low educational level [10].
As people continue to live longer, it is likely that the number
of Alzheimer’s cases will increase. By 2050, it is projected that
approximately 13 million people in the USA and 100 million
people worldwide will be aﬀected by this disease [2, 11]
Increasing evidence indicates AD and other neurodegen-
erative disorders are at least partially mediated by oxidative
stress. Oxidative stress is the state of redox imbalance that
results from a production of reactive oxygen species (ROS)
that exceeds the capacity of antioxidant defense mechanisms
[12]. Environmental exposures such as air pollution can
enhance an organism generation of ROS; thus, air pollution
exposure could very well represent a risk factor for AD
by enhancing oxidative stress processes capable of inducing
physiological alterations of the central nervous system.
Air pollution is a prevalent environmental hazard. In the
USA, National Ambient Air Quality Standards (NAAQSs)
have been established for six principal air pollutants—
criteria air pollutants—proved to represent a threat for
human health. These pollutants include (1) ozone (O3), (2)
particulate matter (PM), (3) carbon monoxide (CO), (4)
nitrogen oxides (NOx), (5) sulfur dioxide (SO2), and (6)
lead. In spite of the current standards, it is estimated that in
the USA over one hundred million people live in areas that
exceed the recommended air quality levels [13].
The large number of individuals exposed to air pollution
levels above the recommended standards and population
aging are two factors that could act synergistically to increase2 Journal of Environmental and Public Health
the prevalence of AD. Even after accounting for the predicted
increase in Alzheimer’s frequency due to population aging,
the signiﬁcant prevalence of air pollution could very well
exacerbate the impact of this disease on public health.
Granting that air pollution could be one of the factors
involved in AD causality, its widespread occurrence makes
ascertaining its association with AD a public health priority.
The association between air pollution—speciﬁcally PM and
O3—and AD via oxidative stress is the focus of this paper.
2. Aging, OxidativeStress, and
Alzheimer’sDisease
2.1.OxidativeStress. Reactiveoxygenspecies(ROS)isaterm
used to collectively refer to “reactive” molecules containing
oxygen, which include free radicals and derivates, and
are capable of leading to oxidative changes within cells
[14–16]. A wide variety of ROS are produced in healthy
tissues in the course of normal metabolism at diﬀerent
cellular sites. However, the main source of ROS is the
mitochondrial electron transport chain, speciﬁcally complex
I(NADH dehydrogenase)and III(ubiquinone-cytochromec
reductase) of the chain [16–21]. Other important generators
of ROS in vivo include peroxisomal fatty acids metabolism,
cytochrome P-450 reactions, phagocytic cells (respiratory
burst), and numerous enzymes [19, 22]. ROS are important
for maintaining oxygen homeostasis in tissues and destruc-
ting microbial invaders [15]. However, they can also cause
oxidative changes within the cell [16] and modify proteins,
lipids, and nucleic acids to develop or enhance age-related
manifestations [12, 21, 23].
Several antioxidant systems—enzymes, vitamins, and
metabolites—protect the cell against ROS-mediated oxida-
tive damage by three key mechanisms: (1) scavenging ROS
and their precursors, (2) binding catalytic metals ions used
for ROS formation, and (3) generating and upregulating
endogenous defense mechanisms [12, 23–27]. The balance
between ROS production and antioxidant defense system
determines the degree of oxidative stress [17]. When ROS
formation exceeds the capacity of the antioxidant defense
systems oxidative stress occurs, which results in oxidative
damage to macromolecules—lipids, proteins, and nucleic
acids—mitochondria, and other cells compartments [12, 16,
19, 22, 24, 25, 27, 28]. Table 1 lists some examples of ROS,
ROS sources, and antioxidant defense mechanisms [17–19,
22, 26].
2.2. Oxidative Stress and Aging. From a biological perspec-
tive, aging is deﬁned as the accumulation of changes over
time responsible for the chronological alterations that occur
with age and result in an increased risk of disease and
death with advanced age [28, 29]. No theory has been
widely accepted to explain the aging process [28]. How-
ever, the oxidative stress hypothesis proposed by Denham
Harman in 1956—the Free Radical Theory of Aging—
oﬀers the best mechanistic explanation of aging and age-
related diseases [28, 29]. Harman’s theory posits a single
common process modiﬁed by genetic and environmental
Table 1: Reactive Oxygen Species (ROS), Sources, and Defense
Mechanisms [17–19, 22, 26].
ROS
Superoxide (O
•−
2 )
Hydrogen peroxide (H2O2)
Hydroxyl radical (•OH)
Peroxyl radicals (ROO•)
Alkoxyl radicals (RO•)
Organic hydroperoxides (ROOR’)
Hypochlorous acid (HOCl)
Peroxynitrite (ONOO−)
Singlet oxygen (1O2)
ROS sources
Endogenous
Mitochondria (byproducts of electron transport)
oxidases (Oxidase-catalyzed reactions)
Inﬂammation (neutrophils, macrophages)
Cytochrome P450 reactions
Arginine metabolism
Peroxisomal fatty acid metabolism (peroxisomes, lipoxygenases)
Exogenous
Ionizing radiation (X–, γ−,U V )
Chemotherapeutics
Inﬂammatory cytokines (macrophages, neutrophils)
Environmental toxins
Antioxidant defense mechanisms
Enzymatic systems
Catalase (CAT)
Superoxide dismutase (SOD)
Glutathione peroxidase (GPx)
Nonenzymatic systems
DNA repair mechanisms
Glutathione
Vitamins (A,C, and E)
Carotenes
factors that is responsible for aging and subsequent death.
Harman argues aging is primarily the result cumulative
damage on macromolecules resulting from free radical
attacks—oxidative stress [28, 30, 31]. This theory was later
expanded to propose mitochondria as the main source of
free radical production [28, 31]. Consequently, aging can
now be described as the result of the accumulation of ROS-
induced damage to macromolecules by free radicals mainly
of mitochondrial origin [19, 28].
In addition to being a main source, mitochondria are
also a major target of ROS. Mitochondrial DNA is especially
vulnerable to oxidative damage because of its proximity to
the site of mitochondrial ROS production (mitochondria),
little protection of its structure (no full histone coat), and
limited repair mechanisms [17, 19–21, 29, 32]. During
normal aging, free radical damage to mitochondria and ROS
production increase and antioxidant mechanisms become
progressively impaired [28, 33]. Consequently, vulnerability
to oxidative stress and accumulation of oxidatively damaged
macromolecules increase with age and may contribute to
aging and age-related degeneration [20, 28].Journal of Environmental and Public Health 3
Although fast replicating cells with low levels of oxygen
consumption do not suﬀer free radical damage, mito-
chondria of highly diﬀe r e n t i a t e dc e l l sw i t hh i g hl e v e l so f
oxygen utilization are highly vulnerable to oxidative stress
[29]. Consequently, neurons are especially vulnerable to
mitochondrial damage by free radicals [29, 34]. Thus, the
detrimental eﬀects of the aging process are best observed
in the brain, where irreversibly damaged cells cannot be
replaced [21].
2.3. Oxidative Stress and Alzheimer’s Disease. The brain—
an organ rich in fatty acids, consumer of high levels of
energy and physiological oxygen, and poor in antioxidant
defense mechanisms—is particularly vulnerable to oxidative
stress [16, 23, 27, 34–38]. Depending on the macromolecule
targeted by ROS, oxidative stress will manifest as lipid perox-
idation, protein oxidation, or DNA oxidation. Accumulation
of oxidation of lipids, proteins, and DNA by free radicals are
responsible for the functional decline in aged brains, which
manifests as a deterioration in cognitive function and motor
skills [12, 19].
Alzheimer’s disease is a progressive and irreversible
neurodegenerative disease manifested as a slowly progressive
dementia, which begins with subtle memory loss and pro-
gresses to severe decline in cognitive function and disability
[1, 39, 40]. The neuropathological hallmarks of AD are
senile plaques and neuroﬁbrillary tangles [41]. Evidence of
an increased oxidation of macromolecules—lipids, carbohy-
drates, proteins, and DNA—and oxidative stress products
has been found in senile plaques and neuroﬁbrillary tangles
[25]. Biomarkers of these forms of oxidation have been
observed not only in AD brains but also in peripheral
tissues (e.g., blood cells) and biological ﬂuids (e.g., urine) of
individuals aﬀected by AD [16, 23, 37, 38, 42–44].
The principal component of senile plaques found in
Alzheimer’s brains is amyloid-beta (Aβ)p e p t i d e[ 45, 46],
which plays an important role in the etiology and progres-
sion of this disease [45]. However, it is unclear whether
Aβ peptide deposition is the cause or the result of the
oxidative stress observed in Alzheimer’s brains [27, 46]. In
the initial phase of the development the disease, Aβ peptide
deposition and the formation of neuroﬁbrillary tangles are
consequences of oxidative stress and may serve as shields to
protect neurons against oxidative damage. However, as the
disease progresses, these evolve into prooxidants driving a
self-sustained “autodestructive” process and the progression
of the disease [16, 47].
Amyloid-beta peptide-related oxidative stress provides
a theoretical framework that unites these two components
in the pathogenesis of AD [46] and suggests two pos-
sible scenarios: ﬁrst, neuronal degeneration could be the
result of an oxidative stress response to senile plaques
and neuroﬁbrillary tangles rather than to these lesions
as such [47]. Second, oxidative stress could be one of
the earliest detectable events in the pathogenesis of AD—
preceding the extracellular deposition of Aβ peptide and
the formation of senile plaques and neuroﬁbrillary tangles
[16, 47].
Olfactory dysfunction is a common feature of AD aﬀect-
ing approximately 90% of AD cases [48]. Olfactory dysfunc-
tion results from the extensive cell loss and neuroﬁbrillary
tangles formation associated with AD that precede Aβ pep-
tide deposition and occur in the olfactory bulb and olfactory
centers (i.e., anterior olfactory nucleolus, periamygdaloid
cortex, and anterior amygdala) in the early stages of AD
[49, 50]. Evidence of oxidative stress has been observed in
the olfactory epithelium of AD cases. Lipid peroxidation in
the nuclear and cell membrane of olfactory neurons and
epithelial cells of AD cases but not in age-matched normal
neuroepithelial cells has been found [51, 52]. In addition, Aβ
peptidedepositionandpairedhelicalﬁlamentsoftauprotein
(precursors of neuroﬁbrillary tangles) are also substantially
more frequent and more abundant in the olfactory epithe-
lium of AD cases than in controls [48, 53]. Additionally,
epidemiological studies indicate that olfactory dysfunction
predicts an increased risk of cognitive decline with advanced
age and takes place before the clinical manifestations of AD
[50, 53, 54]. The occurrence of olfactory pathology in the
early stages of AD and the identiﬁcation of the nose as the
portalofentryofairbornexenobioticsintothebrainsuggests
AD pathology could be mediated by environmental agents
such as air pollutants that could reach the brain through the
olfactory epithelium [50, 55, 56].
3.The Role of AirPollution in
Alzheimer’sDisease
3.1. Air Pollution. Atmospheric air pollution can be deﬁned
as the introduction of any chemical, physical, or biological
pollutant—in the indoor or outdoor air—that modiﬁes the
natural characteristics of the atmosphere and harms human
health and welfare [57]. Air pollutants can be released
into the atmosphere from both natural (e.g., windblown
dust, volcanoes, and wildﬁres) and anthropogenic sources
(e.g.,powerplants,industries,andtransportation).However,
manmade sources are identiﬁed as the major contributor to
indoors and outdoors air pollution [58].
In the USA, NAAQSs for six principal air pollutants (i.e.,
O3,P M ,C O ,N O x,S O 2, and lead) have been established
to protect vulnerable populations (children, older adults,
and individuals living with chronic diseases) against air
pollutants toxicity. Primary and secondary NAAQS for
these six criteria air pollutants are summarized in Table 2
[59].
3.2. Routes of Exposure. Despite the improvements made
in ambient air quality, air pollution continues to be a
prevalent environmental hazard in urban and rural areas.
It is estimated that in the USA 146 million people live in
areas that exceed the recommended air quality standards for
at least one criteria air pollutant—in most cases, O3,P M ,
or both [13]. Human activities aﬀect the timing, location,
and degree of personal exposure to pollutants [60]. Adults,
who generally spend most of their time inside (e.g., at home,
workplace,and/orautomobile),aremorelikelytobeexposed
to indoor air pollution while children, who spend more time4 Journal of Environmental and Public Health
Table 2: National ambient air quility standards (NAAQS) for criteria air pollutants [59].
Criteria air pollutant
Primary standard Secondary standard
Level Averaging Time Level Averaging Time
(1) Ozone 0.075ppm (2008 std) 8 hours Same as primary
(2) Particulate Matter Same as primary
PM2.5
15.0μg/m3 Annual
35μg/m3 24 hours Same as primary
PM10 150μg/m3 24 hours
(3) Carbon Monoxide 9ppm (10mg/m3) 8 hours None
35ppm (40mg/m3) 1 hour
(4) Nitrogen Dioxide∗ 53 ppb Annual Same as primary
100 ppb 1 hour None
(5) Sulfur Dioxide 75 ppb 1 hour 0.5ppm 3 hour
(6) Lead 0.15μg/m3 Rolling 3 month
average
Same as primary
∗Although NAAQS cover the entire group of NOX,N O 2 is use as indicator for this group.
than adults outside, are more likely to encounter outdoor air
pollution [61].
Exposure to air pollution can occur through multiple
routes. The release of pollutants into the atmosphere exposes
humans to hazardous substances primarily by direct inhala-
tion. Transport and deposition of air pollutants into water
and soil also exposes humans to air pollutants through the
ingestion of contaminated water and food [62]. Although
representing a minor route of exposure, dermal contact with
contaminated soil, dust, or water can also contribute to an
individual’s air pollutant intake [58, 62].
3.3. Air Pollution and Human Health. Short- and long-term
exposure to air pollution has consistently been linked to
adverse health outcomes. Exposure to PM and O3 is asso-
ciated with an increased cardiovascular and respiratory
morbidity, mortality, and disability risk [63–68]. Recent esti-
mates indicated that globally about 3% of adult cardiopul-
monary disease mortality, 5% of cancers of the respiratory
systemmortality,andabout1%ofacuterespiratoryinfection
mortality in children in urban areas are attributable to PM,
whichrepresentsaboutonemillionprematuredeathsand6.4
million years of life lost [64].
Epidemiologic studies have shown a positive association
between cardiovascular hospitalizations and ambient NO2,
CO, and PM levels [63, 65, 67, 68]. Exposure to air pollution
has also been associated with reduced lung capacity in
healthy individuals and increased risk of exacerbations,
hospitalizations, and mortality in subjects with respiratory
chronic diseases such as asthma and chronic obstructive
pulmonary disease [66].
3.4. Air Pollution and Oxidative Stress. Oxidative stress
occurs when the production of ROS exceeds the natu-
ral antioxidant systems. This imbalance can result from
exposure to pro-oxidant substances—ROS—present as air
pollutants in the atmosphere [26, 57, 69]. The oxidative
potential of air pollution relies on particle composition
and size distribution and on the presence of transition
metals and semivolatile and volatile organic chemicals [69].
Air pollutants can act directly as prooxidants of lipids
and proteins or as free radical generators by promoting
oxidative stress and inducing inﬂammatory responses after
a threshold—a level at which natural antioxidant mecha-
nisms are overwhelmed—is reached [58, 69, 70]. Autopsy
samples from the frontal cortex of individuals exposed to
urban air pollution indicates that air pollution produces
frontal diﬀerential regulation of genes involved in oxidative
stress, inﬂammation, cell proliferation, diﬀerentiation and
apoptotic death, DNA damage, presynaptic signaling, mem-
brane traﬃcking, and microtubule assembly and stability
[71]. Once natural defense mechanisms are overwhelmed
proinﬂammatory eﬀects follow via the activation of redox-
sensitive transcription factors such as NFκB—nuclear factor
kappa-light chain-enhancer of activated B cells [69]. Thus,
given the large number of people exposed to air pollution,
air pollutants could very well represent a prevalent source
of environmentally induced ROS production [72]a n dt h u s
a risk factor for AD—a neurodegenerative disorder mediated
by oxidative stress.
3.5. Air Pollution and Alzheimer’s Disease. Evidence from
toxicological studies using animal and cellular models
indicates that individuals exposed to high levels of air
pollution show damage in the olfactory mucosa, olfactory
bulb, and frontal cortex region tissues—all similar to that
observed in the AD brains [50, 71, 72]. The presence of
neocorticalhyperphosphorylatedtauwithpretanglematerial
and amyloid-β diﬀuse plaques in the frontal cortex of
individuals exposed to urban air pollution suggests a link
between oxidative stress, neuroinﬂammation, neurodegen-
eration, and chronic exposure to high concentrations of air
pollution [71]. Air pollution can also accelerate amyloid-
beta-42 (Aβ-42) accumulation, which is a known cause of
the neuronal dysfunction that precedes the formation of
Aβ peptide plaques and neuroﬁbrillary tangles [55, 73, 74].Journal of Environmental and Public Health 5
In addition, human studies have shown that exposure to
air pollution impairs cognitive function [75] and induces
cerebrovascular damage [76].
Together, these ﬁndings support a plausible association
between air pollution and AD. Also, they allow us to identify
the human nose as the portal of entry of air pollutants into
the brain [55, 56]. Although AD causality is multifactorial
and thus the result of the interaction of several factors rather
than of a single identiﬁable cause, there is enough evidence
to identify air pollution as an important contributing factor
to the development and expression of the disease. The
interaction between aging, genetic predisposition, and air
pollutioninthecausationofADisdepictedinFigure 1[1,4–
11, 17, 19, 28, 35, 72, 73].
3.5.1. Oxidative Mechanisms of Particulate-Induced Alzheim-
er’s Disease Pathology. Atmospheric particulate matter is a
complex mixture of solid particles and liquid droplets com-
monly found in urban air, and it has shown to be associated
with a variety of adverse health outcomes [58, 65, 77, 78].
The potential for PM to reach the central nervous system
is directly associated with the particles size. Fine particles
with an aerodynamic diameter of less than 2.5μm( P M 2.5)
and ultraﬁne particles of less than 0.1μmo fa e r o d y n a m i c
diameter (UFPM) are the most signiﬁcant for the pathogen-
esis of diseases of the central nervous system [72]. Ultraﬁne
particles can reach the brain by transsynaptic transport
after inhalation through the olfactory epithelium and uptake
through the blood-brain barrier [16, 72, 74]. Deleterious
eﬀects of PM on the brain also vary depending of the
numberofparticles,theirchemicalcompositionandphysical
characteristics, the amount of surface components that are
translocate from the lung to other organs, and the velocity at
which these particles and components are cleared from the
system [72, 74].
The eﬀects of PM on the brain are believed to be the
result of two mechanisms. First, its ability to induce chronic
respiratory and systemic inﬂammation by producing proin-
ﬂammatory cytokines, which aﬀect the blood-brain barrier,
triggers neural-immune interactions and leads to chronic
oxidative stress [16, 56, 75]. Second, its ability to directly
produce ROS can damage the blood-brain barrier and
increases the production of Aβ peptides [75]. Together these
mechanisms are responsible for causing brain inﬂammation
and accelerating the accumulation of Aβ peptide, both of
which are associated with the neuronal dysfunction that pre-
cede the appearance of senile plaques and formation of neu-
roﬁbrillary tangles [55, 74], which are the hallmarks of AD.
3.5.2. Oxidative Mechanisms of Ozone-Induced Alzheimer’s
Disease Pathology. O z o n ei sag a s e o u sa i rp o l l u t a n to r i g -
inated from photochemical reactions between NOX and
VOC in the troposphere. Ozone is the main component of
smog and represents an important problem in urban areas,
especially during the summer when sunlight is abundant.
Emissions from industrial facilities, motor vehicle exhaust,
and gasoline vapors are examples of important sources of
NOX and VOC—the precursors of O3.
Ozone is an ROS and powerful oxidizing agent [72, 79]
capable of inducing oxidative stress state. Animal studies
have indicated that the oxidative eﬀects of O3 on the brain
vary with the duration of the exposure [79] and show a dose-
response relationship [36, 79]. This variation indicates that
even though short O3 exposure induces ROS production,
this occurs at a level that can still be compensated by
antioxidant defense mechanisms. However, as the duration
of the exposure increases, the production of ROS rises and
ﬁnally reaches a threshold dose at which antioxidant defense
mechanisms capacity is exceeded causing brain dysfunction
[36].Thisbraindysfunctionismanifestedasshort-andlong-
termmemorylossandmotordeﬁciencyinrats,allalterations
that are positively related to the duration of O3 exposure
[36, 79].
Besides causing motor deﬁciency and memory loss, O3
can also cause neuroinﬂammation, neuronal damage, and
alterationsofthecerebralvasculature[36,72].Moreover,O3-
induced oxidative stress can cause dysregulation of inﬂam-
matory processes, progressive neurodegeneration, chronic
loss to brain repair in the hippocampus, and brain plasticity
changes in rats, which are comparable to those observed
in AD disease patients [79]. Although there is evidence
showing the oxidative changes caused by O3 on the brain,
the mechanisms through which this gas reaches and aﬀects
the brain are yet to be understood [36, 72] and should
consequently motivate future research eﬀorts.
4. FutureDirections
In this paper we discussed the current evidence describing
an association between exposure to air pollution and AD.
Although evidence from toxicological studies using animal
and cellular models is abundant, epidemiological evidence is
limited. Thus, the potential link between air pollution and
AD at the population level remains unclear. More research is
needed to characterize the association between exposure to
air pollution and AD and its implications for public health.
At the individual level, eﬀorts should be oriented toward
determining the routes through which each air pollutant
reaches the brain, as well as the biological mechanisms
through which they contribute to the development and
clinical manifestation of AD. Speciﬁcally, the eﬀects of PM
and O3 on the brain have been the focus of many studies;
however, exposure to VOC is yet to be described. Also, and
because air pollution consists of a mixture of diﬀerent air
pollutants (i.e., particles, liquid droplets, and gases), further
investigation on the potential additive or synergistic eﬀects
between these pollutants is imperative.
The identiﬁcation of air pollution as a factor in the
pathogenesis and etiology of AD on the population level
could provide a strong basis for implementing novel public
health initiatives that could prevent AD for reaching epi-
demic proportions. By controlling the environmental factors
that contribute to the pathogenesis of AD, public health
professionals could also eﬀectively minimize the burden AD
is projected to place on worldwide healthcare systems in the
decades to come.6 Journal of Environmental and Public Health
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Cerebrovascular damage
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Figure 1: Interacting factors in the causality of Alzheimer’s disease [1, 4–11, 17, 19, 28, 35, 72, 73]. Alzheimer’s disease is the result of
the interaction of aging, genetic predisposition, and environmental exposures such as air pollution in the etiology and pathogenesis of the
disease. Air pollution is a prevalent environmental source of ROS that impacts the brain through the multiple pathways accelerating the
development and clinical manifestation of Alzheimer’s disease. BBB: blood-brain barrier; ROS: reactive oxygen species; CVD: cardiovascular
disease.
5. Conclusion
Air pollution has consistently been identiﬁed as a signiﬁcant
environmentalhazardanditsassociationwithcardiovascular
and respiratory disease is well established. Recent reports
from toxicological studies indicate the existence of an
association between air pollution and central nervous system
disease. Depending on their characteristics air toxicants can
reach the brain through several pathways. The eﬀects of air
pollution on the brain then manifest as neuroinﬂammation,
oxidative stress, and neurodegeneration.
Although AD causality is multifactorial, air pollution
could increase an individual’s risk of developing AD by
accelerating age-related oxidative changes observed in the
brain and hence represent a signiﬁcant public health hazard.
Therefore, the control of environmental factors such as air
pollution could be a key factor in limiting the predicted
i n c r e a s ei nA Dc a s e s ,a sw e l la st h eb u r d e ni ti se x p e c t e dt o
have on healthcare systems, worldwide.
Despite the many studies investigating the association
between air pollution and AD, the role of air pollution in
the causation and pathogenesis of this neurodegenerative
disorder is not fully understood. Individual factors that
could mediate the association between air pollution and AD
such as age, nostril size, daily activities, and concomitant
health conditions need further investigation. In addition,
epidemiological studies looking at the association between
air pollution and AD are few. Therefore, the implications
of the association between air pollution and AD at a
populationlevelremainunclear.ThepredictedburdenofAD
on public health and the health care system should further
motivate future research oriented toward providing evidence
toobtainabetterunderstandingofthisassociationandguide
preventive eﬀorts.
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